Washington, April 13 ANI | 8 months ago

Scientists have revealed that a new Chinese herbal medicine could the significant potential of treating Hepatitis C.

The researchers have found that a new compound, SBEL1, which has been isolated from Chinese herbal medicines, has the ability to inhibit hepatitis C virus (HCV) activity in cells at several points in the virus' lifecycle.

The study showed that the compound could inhibit HCV activity by approximately 90 percent.

The scientists, who pre-treated human liver cells in vitro with SBEL1 prior to HCV infection, found that SBEL1 pre-treated cells contained 23 percent less HCV protein than the control, suggesting that SBEL1 blocks virus entry.

Markus Peck-Radosavljevic, Secretary-General of the European Association for the Study of the Liver and Associate Professor of Medicine, said that people infected with hepatitis C are at risk of developing severe liver damage including liver cancer and cirrhosis and that SBEL1 has demonstrated significant inhibition of HCV at multiple stages of the viral lifecycle.

(Posted on 14-04-2014)

Share This Page: